Risk of medication-induced lactic acidosis and hyperlactatemia: a pharmacovigilance study of the United States Food and Drug Administration’s Adverse Event Reporting System database

ObjectiveLactic acidosis and hyperlactatemia (LAHL) are predictors of poor clinical outcomes in critically ill patients. This research aimed to specify medications reported in association with LAHL, thus providing valuable insights into medication safety.MethodsSpontaneous reports were excavated fro...

Descrición completa

Detalles Bibliográficos

Principais autores:	Houci Yang, Haibin Dai, Xveying Chen, Jiaqi Huang, Fangzhou Miao, Jiani Lv, Jiali Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Pharmacology
Assuntos:	lactic acidosis hyperlactatemia pharmacovigilance FAERS adverse reaction
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1555955/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!